Tagra Biotechnologies, since its inception in 1998, focuses on developing and manufacturing microencapsulated ingredients such as actives, pigments, essential oils, UV filters, and highly water-soluble ingredients.
Tagra is the first to patent a unique innovative Release on Demand™ (RND™) Microencapsulation Technology. Tagra’s platform addresses industry challenges of stability, efficiency, and compatibility with other cosmetic and pharmaceutical formulation ingredients. The technology enables the masking, protecting, and releasing of more than 40 actives and pigments widely used in cosmetics and OTC preparations. Tagra’s microcapsules are friction released through consumer applications.
Tagra also owns and operates its own plant and state-of-the-art laboratory meeting all required regulations.
WS SA50™ consists of encapsulated Salicylic Acid, 50% payload. WS SA50™ increases Salicylic Acid water solubility from 0.2% to 5% and maintains an acidic pH.
Upgrade to a premium Prospector account to filter by ingredient properties and view compliance highlights. These features can help you make smarter formulation decisions with instant access to:
Search by physical and chemical properties. Personal Care & Cosmetics only.
We're sorry, but the industry you have selected is not currently available in your chosen language. You may choose a language below to continue to this industry or close this dialog above.